Fishman Jay A Ltd. MI Has $286,000 Holdings in HCA Healthcare Inc (NYSE:HCA)

Fishman Jay A Ltd. MI lessened its stake in HCA Healthcare Inc (NYSE:HCA) by 3.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,375 shares of the company’s stock after selling 75 shares during the quarter. Fishman Jay A Ltd. MI’s holdings in HCA Healthcare were worth $286,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. raised its position in HCA Healthcare by 0.4% during the second quarter. Vanguard Group Inc. now owns 20,865,021 shares of the company’s stock worth $2,820,324,000 after acquiring an additional 88,231 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of HCA Healthcare by 9.5% during the second quarter. Price T Rowe Associates Inc. MD now owns 15,906,139 shares of the company’s stock valued at $2,150,033,000 after purchasing an additional 1,375,021 shares in the last quarter. Magellan Asset Management Ltd lifted its holdings in shares of HCA Healthcare by 21.0% during the second quarter. Magellan Asset Management Ltd now owns 15,621,068 shares of the company’s stock valued at $2,111,500,000 after purchasing an additional 2,712,130 shares in the last quarter. Longview Partners Guernsey LTD lifted its holdings in shares of HCA Healthcare by 9.4% during the second quarter. Longview Partners Guernsey LTD now owns 9,487,250 shares of the company’s stock valued at $1,282,392,000 after purchasing an additional 813,474 shares in the last quarter. Finally, Nuveen Asset Management LLC lifted its holdings in shares of HCA Healthcare by 1,105.9% during the second quarter. Nuveen Asset Management LLC now owns 3,165,181 shares of the company’s stock valued at $427,837,000 after purchasing an additional 2,902,715 shares in the last quarter. Hedge funds and other institutional investors own 70.19% of the company’s stock.

HCA stock traded up $0.63 during trading on Friday, reaching $136.84. The stock had a trading volume of 862,637 shares, compared to its average volume of 1,658,266. HCA Healthcare Inc has a 52 week low of $110.31 and a 52 week high of $147.42. The stock’s 50 day moving average is $124.24 and its two-hundred day moving average is $127.34. The firm has a market cap of $45.57 billion, a PE ratio of 14.01, a PEG ratio of 1.14 and a beta of 0.90.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, October 29th. The company reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.13 by $0.10. HCA Healthcare had a negative return on equity of 173.49% and a net margin of 6.98%. The company had revenue of $12.69 billion for the quarter, compared to the consensus estimate of $12.48 billion. During the same quarter in the prior year, the company earned $2.16 earnings per share. HCA Healthcare’s revenue was up 10.9% on a year-over-year basis. Research analysts predict that HCA Healthcare Inc will post 10.52 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 2nd will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date is Friday, November 29th. HCA Healthcare’s dividend payout ratio is 16.38%.

In other HCA Healthcare news, SVP Deborah M. Reiner sold 749 shares of the stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $136.67, for a total value of $102,365.83. Following the transaction, the senior vice president now owns 8,237 shares of the company’s stock, valued at $1,125,750.79. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Christopher F. Wyatt sold 3,900 shares of the stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $134.74, for a total value of $525,486.00. Following the completion of the transaction, the senior vice president now directly owns 27,353 shares in the company, valued at approximately $3,685,543.22. The disclosure for this sale can be found here. In the last three months, insiders sold 39,553 shares of company stock worth $5,282,165. 2.70% of the stock is owned by corporate insiders.

A number of research analysts have recently issued reports on the company. Mizuho set a $153.00 price target on HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, July 31st. Stephens set a $150.00 price target on HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, August 7th. Robert W. Baird upped their price target on HCA Healthcare from $155.00 to $160.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Bank of America raised HCA Healthcare from an “underperform” rating to a “neutral” rating and upped their price target for the company from $130.00 to $137.00 in a report on Friday, September 6th. Finally, ValuEngine raised HCA Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $155.07.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Google Finance Portfolio

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.